CMB Share Price Performance
AU$0.53
0.12 (28.05%)
Price AU$0.53
Share PriceAU$0.53
Cambium Bio Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
CMB Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Cambium Bio Limited Key Details
About CMB
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
